Market Intelligence chevron_right Service & Software chevron_right Next Generation Sequencing (NGS) Solution
Global Report 2025

Global Next Generation Sequencing (NGS) Solution Market Growth (Status and Outlook) 2025-2031

calendar_todayPublished: Jun 2025 descriptionPages: 123 categoryCategory: Service & Software
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount

The global Next Generation Sequencing (NGS) Solution market size is predicted to grow from $5400 million in 2025 to $13140 million in 2031; it is expected to grow at a CAGR of 16.0% from 2025 to 2031.

Next Generation Sequencing (NGS), also known as high-throughput sequencing, refers to advanced genomic technologies that enable the rapid and cost-effective sequencing of DNA or RNA molecules. NGS solutions have revolutionized the field of genomics and have significant applications in various areas of life sciences, including medical research, diagnostics, personalized medicine, agriculture, and environmental studies.

Key Features:

  • Significant growth in the global NGS market due to increasing adoption of NGS technologies.
  • Revolutionized genomics research and precision medicine.
  • Continuous innovations in NGS platforms, sequencing chemistries, and bioinformatics tools.

Segmentation by Type:

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing and Resequencing Centrifuges

Segmentation by Application:

  • Sporadic Cancer
  • Inherited Cancer
  • Companion Diagnostics
  • Others

Market by Region:

  • Americas: United States, Canada, Mexico, Brazil
  • APAC: China, Japan, Korea, Southeast Asia, India, Australia
  • Europe: Germany, France, UK, Italy, Russia
  • Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Company's Coverage:

  • Eurofins Scientific
  • Illumina
  • PerkinElmer
  • Thermo Fisher Scientific
  • Roche Holding
  • Agilent Technologies
  • Myriad Genetics
  • Foundation Medicine
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Paradigm Diagnostics
  • BGI Group
  • Caris Life Sciences
  • Partek
  • Natera
  • LabCorp
  • Macrogen
  • Genotypic Technology

Key Questions Addressed in this Report:

Frequently Asked Questions

What is the USP of the report? expand_more
Next Generation Sequencing (NGS) Solution report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Next Generation Sequencing (NGS) Solution report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Next Generation Sequencing (NGS) Solution report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.